tiprankstipranks
Creo Medical Partners with Micro-Tech for Strategic Growth
Company Announcements

Creo Medical Partners with Micro-Tech for Strategic Growth

Creo Medical (GB:CREO) has released an update.

Pick the best stocks and maximize your portfolio:

Creo Medical Group plc has announced the sale of a 51% stake in its European subsidiary to Micro-Tech (Nanjing) Co. Ltd for €36.7m, which will enhance Creo’s balance sheet and enable continued investment in its core business. This strategic partnership is set to expand Creo’s endoscopic therapy product range and strengthen its commercial platform, with expectations for the deal to complete in Q1 2025. Creo Europe’s managing director will remain, ensuring continuity in the business’s operation alongside the new partnership.

For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskCreo Medical Chairman Increases Stake with Significant Share Purchase
TipRanks UK Auto-Generated NewsdeskCreo Medical Reports Share Capital and Voting Rights
TipRanks UK Auto-Generated NewsdeskCreo Medical CFO’s Strategic Share Transaction
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App